Ramachandran Vinayagam

Dr. Ramachandran Vinayagam

yeungnam university, Gyeongsan, Gyeongbuk, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2015 in Nutrition & Metabolism
Verified
Journal Article
Open access
PDF file
RVRamachandran Vinayagam
Ramachandran Vinayagam
Baojun XuBaojun Xu
Baojun Xu
Natural food products have been used for combating human diseases for thousands of years. Naturally occurring flavonoids including flavones, flavonols, flavanones, flavonols, isoflavones and anthocyanidins have been proposed as effective supplements for management and prevention of diabetes and its long-term complications based on in vitro and animal models. To summarize the roles of dietary flavonoids in diabetes management and their molecular mechanisms. Tremendous studies have found that flavonoids originated from foods could improve glucose metabolism, lipid profile, regulating the hormones and enzymes in human body, further protecting human being from diseases like obesity, diabetes and their complications. In the current review, we summarize recent progress in understanding the biological action, mechanism and therapeutic potential of the dietary flavonoids and its subsequent clinical outcomes in the field of drug discovery in management of diabetes mellitus.

4 December 2015 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
RVRamachandran Vinayagam
Ramachandran Vinayagam
MJMuthukumaran Jayachandran
Muthukumaran Jayachandran
Baojun XuBaojun Xu
Baojun Xu

1 October 2019 in Microbial Pathogenesis
Verified
Journal Article
Closed access
Mariadoss Arokia Vijaya AnandMariadoss Arokia Vijaya Anand
Mariadoss Arokia Vijaya Anand
RVRamachandran Vinayagam
Ramachandran Vinayagam
VSVijayakumar Shalini
Vijayakumar Shalini
ABAgilan Balupillai
Agilan Balupillai
JFJebaraj Herbert Franklin
Jebaraj Herbert Franklin
EDErnest David
Ernest David

21 August 2019 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
Mariadoss Arokia Vijaya AnandMariadoss Arokia Vijaya Anand
Mariadoss Arokia Vijaya Anand
RVRamachandran Vinayagam
Ramachandran Vinayagam
VRVinothkumar Rajamanickam
Vinothkumar Rajamanickam
VSVijayalakshmi Sankaran
Vijayalakshmi Sankaran
SVSathish Venkatesan
Sathish Venkatesan
EDErnest David
Ernest David
Over the past two decades, many researchers have concluded that a diet rich in polyphenolic compounds plays an important therapeutic role in reducing the risk of cancer, cardiovascular disease, inflammation, diabetes, and other degenerative diseases. Polyphenolic compounds have been reported to be involved in neutralization of reactive oxygen species and charged radicals, and have anticarcinogenic effects, hepatoprotective effects, low-glycaemic response, and other benefits. The benefits of fruits and vegetables may be partly attributable to polyphenolic compounds, which have antioxidant and free radical scavenging properties. Fruits such as apples contain a variety of phytochemicals, including (+)-catechin and (-)-epicatechin, phlorizin, phloretin quercetin, cyanidin-3-Ogalactoside, chlorogenic acid, and p-coumaric acid, all of which are strong antioxidants. Phloretin, a natural phenolic compound, is a dihydrochalcone, which is present in the apple. It exhibits a wide variety of activities such as antioxidative, anti-inflammatory, anti-microbial, anti-allergic, anticarcinogenic, anti-thrombotic, and hepatoprotective, besides being involved in the activation of apoptotic associated gene expression and signal transduction in molecular pathways. Despite a multitude of clinical studies, new efforts are needed in clinical research to determine the complete therapeutic potential of phloretin.

1 January 2013 in Journal of Acute Disease
Verified
Journal Article
Open access
JMJayachandran Muthukumaran
Jayachandran Muthukumaran
SSSubramani Srinivasan
Subramani Srinivasan
RVRantham Subramaniyam Venkatesan
Rantham Subramaniyam Venkatesan
RVRamachandran Vinayagam
Ramachandran Vinayagam
UMUdaiyar Muruganathan
Udaiyar Muruganathan
ObjectiveTo evaluate the antidiabetic effect of syringic acid, a natural phenolic compound on the levels of glycoprotein components in plasma and tissues of alloxan induced diabetic rats.MethodsDiabetes was induced in male Wistar rats by a single intraperitoneal injection of alloxan (150 mg/kg b.w). Syringic acid (50 mg/kg b.w) was administered orally for 30 d. The effects of syringic acid on plasma glucose, insulin, C-peptide, plasma and tissue glycoproteins were studied.ResultsOral administration of syringic acid (50 mg/kg b.w) for 30 d positively modulates the glycemic status in alloxan induced diabetic rats. The levels of plasma glucose were decreased with significant increase of plasma insulin and C-peptide level. The altered levels of plasma and tissue glycoprotein components were restored to near normal. No significant changes were noticed in normal rats treated with syringic acid.ConclusionsThe present findings suggest that syringic acid can potentially ameliorate glycoprotein components abnormalities in addition to its antidiabetic effect in experimental diabetes, further clinical studies are required to evaluate the use of syringic acid as an effective therapeutic agent for the treatment of diabetes mellitus

18 August 2015 in Human & Experimental Toxicology
Verified
Journal Article
Closed access
RVRamachandran Vinayagam
Ramachandran Vinayagam
RSR Saravanan
R Saravanan
In this study, we examined the in vivo effect and the mechanism of asiatic acid (AA) on glucose uptake in an insulin target skeletal muscle. Diabetic rats showed significantly increased levels of plasma glucose, thiobarbituric acid reactive substances, and lipid hydroperoxides, decreased levels of insulin and antioxidants, and impairment in insulin-signaling proteins such as insulin receptor (IR), insulin receptor substrate (IRS)-1/2, phosphoinositide 3-kinase (PI3K), Akt, and glucose transporter 4 (GLUT4) proteins. Oral treatment with AA (20 mg/kg body weight) showed near-normalized levels of plasma glucose, lipid peroxidation products, and antioxidants and improved insulin, IR, IRS-1/2, PI3K, Akt, and GLUT4 proteins. These findings suggest that AA improves glucose response by increasing GLUT4 in skeletal muscle through Akt and antioxidant defense in plasma and it also improves glucose homeostasis.